Authors
Latest:
Building Crisis Management and Risk Mitigation Plans into Patient Support ProgramsIn simple terms, patient support programs help get medicines into the hands of people who need them.
Latest:
A Biosimilars Roadmap: Understanding Payer PerceptionsWith competition for follow-on-biologics on the upswing—and a potential market boom perhaps around the corner—continued education and course-setting for all stakeholders in charting the access landscape is paramount.
Latest:
No Half Measures: How Medical Affairs Can Maximize and Measure ValueEducation and knowledge transfer must be prioritized for industry to see sizable improvement in medical affairs.
Latest:
Key Considerations for Senior Executives Related to Quality CultureExploring practical points to further understand and strengthen quality culture.
Latest:
5 Lessons Learned from Embracing Agile in Commercial LaunchAgile methodologies provide an alternative to hierarchical, siloed and sequential way of managing activities and have the potential to dramatically reduce set-up time for new business or digital capabilities.
Latest:
Understanding the HCP: Patient-Level Data Proves ValuableEvaluating patient data in the context of complementary information can provide comprehensive market insights for product strategy.
Latest:
Embracing Generative AI: Why Its Disruption is Positive for PharmaThe new era of generative AI is poised to impact pharma marketing and engagement in powerful and lasting ways. But amid all the technological praise, what are the key considerations brand teams must navigate?
Latest:
Measuring Pharma’s Trust PerformanceThe core building blocks of trust must be operationalized for pharma companies to strengthen their social contract, deliver business value, and improve patients’ quality of life.
Latest:
The American Rescue Plan Act of 2021: Pharmaceutical Industry ImpactAssessing the implications for the pharma industry of the America Rescue Plan Act of 2021, which provides nearly two trillion dollars in funding for various government programs, including many related to public health.
Latest:
Billing Codes for DTx Would Open the Floodgates for Behavioral Health EquityApproval of Medicare and Medicaid coverage for digital therapeutics represents next step in advancing care for mental health patients.
Latest:
Emergency Use Authorization: What We’ve Learned Bringing COVID-19 Therapies to MarketPandemic forces pharma companies to work faster and smarter to meet hard deadlines.
Latest:
As Pharma Continues to Adapt to AI, the POSA Standard will Need to Equally AdaptU.S. patent law will have to adapt to the use of AI in the life sciences industry.
Latest:
Transforming Healthcare Data to Precision MedicineA modern healthcare ecosystem involves various stakeholders and many forms of complex data. Collaborations and a range of advanced approaches are essential to providing more uniform and complete healthcare to patients.
Latest:
Empathy: The Foundation of Health LiteracyGoing beyond the words of healthcare communication.
Latest:
Not Just Another Tactic: Why Pharmaceutical Brands Need to Build a Strategy Around Point of Care MessagingPoint of care messaging offers unique advantages in pharmaceutical marketing and should be a high priority in brand strategy discussions.
Latest:
Partnering to Respond to a Possible Nuclear ThreatRecent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.
Latest:
Delivery and Disruption: Navigating a Changing Care TerrainThe diversification of site-of-care delivery models is accelerating rapidly, creating new go-to-market implications for drug manufacturers—but also new opportunities to drive more fundamental innovation in engagement and access strategies.
Latest:
Staying the Course: Double Down on Launch AgilityIn today’s fragmented commercial environment, navigating a more complex set of challenges while adapting new approaches to product launch is critical for biopharma brand teams.
Latest:
China’s 2022 NRDL OutlookThe 2022 National Reimbursement Drug List will see more pressures for new inclusions on the one hand, and more certainties for renewals on the other. At the same time, the process is becoming more interactive and transparent.
Latest:
The Top 5 Golden Opportunities for Pharma RecruitmentPharma companies must revise their recruitment strategies in the wake of a skills shortage.
Latest:
Transfer Responsibility with SaaS: Trade Outdated LIMS Technology and IT Hassles for Zero-touch MaintenanceAs today’s labs continue to evolve, the software solutions that support them must too. Likewise, laboratory and organization leadership must be open to the advance¬ments available to them from modern technologies. In this white paper, learn how a SaaS-based LIMS modernization program optimizes data management, fosters collaboration, and improves decision-making to stay at the forefront of scientific innovation.
Latest:
The EU Regulations Catching US Pharma Companies Off GuardCompanies that understand the regulatory environment in Europe can keep their trials on budget and on schedule.
Latest:
NFTs: What This New Kid on the Blockchain Means for HealthcareThere has been a push to implement NFTs, or non-fungible tokens, across many verticals, but there is still much to learn about their potential uses in healthcare and its brands.
Latest:
The Real Value of AI in Healthcare? Strengthening the Doctor-Patient RelationshipWhy empowering both parties with the tools and data they need to make clinical decisions should be a top priority in the AI renaissance—to bolster patient care and improve health outcomes.
Latest:
Elevating ESG Message: Today’s Modern Investor is KeyHow pharma companies can make sure their corporate strategy in ESG is appealing to younger generations—and aligns with the issues this large segment of sustainability investors care about most.
Latest:
5 Signs You Need Digital Healthcare Marketing SupportHow far should your digital strategy reach? Daniel King and Simon Davies offer five signs that indicate you need better digital support.
Latest:
The C-Suite’s Frontline Workers in Digital ChangeHow the CIO role has transformed and strengthened against the backdrop of COVID-19.
